Abstract

Abstract Purpose: Breast cancer is the most common type of cancer for women nationally with evidence indicating clear racial and ethnic disparities in risk and occurrence. Yet our understanding of the distinct, population-level impacts among Native Hawaiian and Pacific Islander (NHPI) women is limited. NHPIs show elevated levels of multiple comorbidities and emerging evidence from local community studies suggests NHPIs suffer disproportionately from higher incidence, advanced stage of diagnoses, and lower survivability rates from breast cancer. The purpose of this study was to investigate the prevalence, sociodemographic characteristics, and risk factors associated with NHPI women diagnosed with breast cancer. Methods/Data: We utilized the 2014 Native Hawaiian and Pacific Islander National Health Interview Survey (NHPI NHIS), a nationally representative survey conducted by the CDC-NCHS to collect high-quality data on health conditions, health risk behaviors, and healthcare utilization among NHPI populations. Among 2,588 participants, 4% reported having ever been diagnosed with cancer, and among those breast cancer was the most common. Descriptive and regression analysis of socio-demographic characteristics, risk behaviors, and comorbidities to evaluate disparities in the incidence of breast cancer among NHPI women compared to other racial or ethnic populations. Findings/Conclusion: Population-based estimates of breast cancer prevalence among a diverse NHPI population show breast cancer inequities persist. Ongoing research is needed to better understand the underlying conditions and risks, prevention, and treatment of breast cancer in the population. Citation Format: Sarah A. McNally, Daniel J. Salas-Escabillas, Nicholas A. Sowizral, Sela V. Panapasa. Prevalence and risk factors of breast cancer diagnoses among Native Hawaiian & Pacific Islander women [abstract]. In: Proceedings of the 16th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2023 Sep 29-Oct 2;Orlando, FL. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2023;32(12 Suppl):Abstract nr A118.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call